alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 70, Number 225 (Wednesday, November 23, 2005)]
[Notices]
[Page 70856]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-23194]



[[Page 70856]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and percent information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Initial Review 
Group, Subcommittee C--Basic & Preclinical.
    Date: December 13-14, 2005.
    Time: 8 a.m. to 2 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Marriott Bethesda North Hotel and Conference Ctr., 5701 
Marinelli Road, North Bethesda, MD 28052.
    Contact Person: Michael B. Small, PhD, Scientific Review 
Administrator, Research Programs Review Branch, Division of 
Extramural Activities, National Cancer Institute, National 
Institutes of Health, 6116 Executive Boulevard, Room 8127, Bethesda, 
MD 20892, 301-402-0996, <a href="/cdn-cgi/l/email-protection#02716f636e6e6f426f636b6e2c6c6b6a2c656d74"><span class="__cf_email__" data-cfemail="483b2529242425082529212466262120662f273e">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: November 8, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-23194 Filed 11-22-05; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
NY:1800719v1 

James S. Frank (JF – 5389) 

EPSTEIN BECKER & GREEN, P.C. 

250 Park Avenue 

New York, NY 10177 

(212) 351-4500 

Attorneys for Defendant 

The New York and Presbyterian Hospital 

UNITED STATES DISTRICT COURT 

SOUTHERN DISTRICT OF NEW YORK 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - x 

CAROLYN A. GRAY, 

Plaintiff, 

- against - 

LOCAL UNION 1199, COLUMBIA 

PRESBYTERIAN MEDICAL CTR., AND 

NEW YORK PRESBYTERIAN OF 

COLUMBIA AND CORNELL 

 Defendants. 

: 

: 

: 

: 

: 

: 

: 

: 

: 

: 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - x 

07-CV-3238 (AKH) (GWG) 

NOTICE OF APPEARANCE

Original Filed by ECF 

TO THE CLERK OF THIS COURT AND ALL PARTIES OF RECORD: 

PLEASE TAKE NOTICE that the undersigned enters an appearance as counsel 

for defendant The New York and Presbyterian Hospital erroneously identified as “Columbia 

Presbyterian Medical Center and New York Presbyterian of Columbia and Cornell,” in the 

above-captioned action. Please serve all papers related to this action upon the undersigned. 

Dated: April 30, 2007 

 New York, New York 

EPSTEIN BECKER & GREEN, P.C. 

By: /s/ James S. Frank 

 James S. Frank (JF-5389) 

250 Park Avenue 

New York, New York 10177-1211 

(212) 351-4500 

Attorneys for Defendant The New York and 

Presbyterian Hospital 

Case 1:07-cv-03238-AKH Document 6 Filed 04/30/2007 Page 1 of 1
Case 1:07-cv-03462-JFK Document 35 Filed 08/12/2008 Page 1 of 4Case 1:07-cv-03462-JFK Document 35 Filed 08/12/2008 Page 2 of 4Case 1:07-cv-03462-JFK Document 35 Filed 08/12/2008 Page 3 of 4Case 1:07-cv-03462-JFK Document 35 Filed 08/12/2008 Page 4 of 4
[Federal Register Volume 70, Number 225 (Wednesday, November 23, 2005)]
[Notices]
[Page 70855]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-23193]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Initial Review 
Group, Subcommittee D--Clinical Studies.
    Date: December 13-14, 2005.
    Time: 9 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Marriott Bethesda North Hotel & Conference Center, 5701 
Marinelli Road, North Bethesda, MD 20852.
    Contact Person: William D. Merritt, PhD, Scientific Review 
Administrator, Research Programs Review Branch, National Cancer 
Institute, Division of Extramural Activities, 6116 Executive Blvd., 
8th Floor, Bethesda, MD 20892-8328, 301-496-9767, <a href="/cdn-cgi/l/email-protection#4e3923787d280e20272660292138"><span class="__cf_email__" data-cfemail="146379222772547a7d7c3a737b62">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 39.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: November 8, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-23193 Filed 11-22-05; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Pursuant to
section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of EPCOS AG, a Germany company (the Company), hereby certifies, to such
officers knowledge, that:



The Annual
Report on Form 20-F for the year ended September 30, 2002 (the Report) of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Report fairly
presents, in all material respects, the financial condition and results of operations of the Company.



Date: March 24, 2003



/s/    Gerhard PegamGerhard Pegam Chief Executive Officer




A
signed original of this written statement required by section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.



The foregoing certification is being furnished solely pursuant
to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code) and is not being filed as part of the Report or as a separate disclosure document.



---



Pursuant to
section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of EPCOS AG, a Germany company (the Company), hereby certifies, to such
officers knowledge, that:



The Annual
Report on Form 20-F for the year ended September 30, 2002 (the Report) of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Report fairly
presents, in all material respects, the financial condition and results of operations of the Company.



Date: March 24, 2003



/s/    Bodo LüttgeDr. Bodo Lüttge Chief Financial Officer




A
signed original of this written statement required by section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.



The foregoing certification is being furnished solely pursuant
to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code) and is not being filed as part of the Report or as a separate disclosure document.
#### BERNARD LAMB, MAYOR OF THE BOROUGH OF HO-HO-KUS, PROSECUTOR, v. A. D. McKEE, INCORPORATED, ET AL., DEFENDANTS.

Submitted May 16, 1931

Decided May 6, 1932.

Before Justices Tbekchabd and Dokgbs.

For the prosecutor, *Jacob W. & Edgar A. De Yoe.*

For the defendants, *De Turclc & West.*

*650Pee Cubiam.

This writ brings up orders of the Bergen County Court of Common Pleas, setting aside four convictions of the defendant A. D. McKee, Incorporated, for violations of the zoning ordinance of the borough of Ho-Ho-Kus.

The zoning ordinance was passed June 6th, 1923, and the Enabling act was passed in 1928. *Pamph. L., p.*696. The defendant was the owner of a ten-acre lot of land in the borough, acquired in 1927. From this tract it was excavating sand and gravel, although only one. acre was being worked at that time. After the Enabling act was passed the defendant continued to make excavations from other portions of the tract, and complaints were made for the violation of the ordinance. The defendant company was convicted of nonconforming use of the land, non-conforming use of the building, use of the land without certificate of occupancy, and use of the building without certificate of occupancy.

Upon appeal the convictions by the recorder of the borough were reversed by the Court of Common Pleas, and the borough obtained this writ.

The situation presented is very similar to that passed upon by the Court of Errors and Appeals in *Frank J. Durkin Lumber Co.*v. *Fitzsimmons,*106 *N. J. L.*183; 147 *Atl. Rep.*566, for the ordinance here in question is subject to the same infirmity as that there in question, and that case held that a con-conforming use that was lawful when instituted, and actively and constantly maintained, was entitled to be continued under the act of 1928.

The prosecutor of this writ admits that as to the one acre of the lot used before the passage of the Enabling act of 1928, the defendant is protected by the rule laid down in Durkin Lumber Co. *v.*Fitzsimmons. It, however, attempts to differentiate that case from the instant one by saying that the excavation from parts of the remaining nine acres was a new use commenced after the zoning ordinance became valid. The Common Pleas judge held that the tract was a unit and came within the definition of a lot in the sense that lot was used in section 11 of the act of 1928, citing *Edwards*v. *Der**651rickson, 28 *N. J. L.*45. That view we think is sound. We think the tract as a whole was used for excavating purposes even though only a part of it was actually being dug. Under prosecutor’s reasoning a land owner would be entitled to continue a previous non-conforming use only on the precise spot where it was being done. We think that is not so, and was not the intention of the legislature in enacting section 11 of the act of 1928. We think that the tract was a single unit and that it was put to a non-conforming use as a whole before the act of 1928 was passed.

The four orders under review will be affirmed and the writ dismissed, with costs.
Exhibit 10.20
   
  Re:
    
    Management Agreement Renewals
   
    
    Smith Barney Potomac Futures Fund L.P.
    
    Smith Barney Diversified Futures Fund L.P.
    
    Smith Barney Diversified Futures Fund L.P. II
    
    Smith Barney Global Diversified Futures Fund L.P.
    
    Salomon Smith Barney Diversified 2000 Futures Fund L.P.
    
    CMF Campbell Master Fund L.P.
   CITIGROUP MANAGED FUTURES LLCBy:
    /s/ Jennifer MagroJennifer Magro 
Chief Financial Officer & Director CAMPBELL & COMPANY, INC.By:


/s/
Thomas P. Lloyd Thomas P. Lloyd




---



##### 



Exhibit 10.20
  th
  Re: Management Agreement Renewals
   
    
    Salomon Smith Barney Global Diversified Futures Fund L.P.
    
    Salomon Smith Barney Diversified 2000 Futures Fund L.P.
    
    Citigroup Diversified Futures Fund L.P.
    
    Citibank NA (Alera 100)
    
    CMF Aspect Master Fund L.P.
    
    CMF Institutional Futures Portfolio LP
    
    Citigroup Global Futures Fund Ltd.
   CITIGROUP MANAGED FUTURES LLCBy:
    /s/ Jennifer MagroJennifer MagroChief Financial Officer & Director By:

/s/
Simon Rockall Simon Rockall




---



##### 



Exhibit 10.20
  
  Re: Management Agreement Renewals
   
    
    Salomon Smith Barney Diversified 2000 Futures Fund L.P.
    
    Salomon Smith Barney Fairfield  Futures Fund L.P.
    
    Smith Barney Diversified Futures Fund L.P. II
    
    Smith Barney Diversified Futures Fund L.P.
    
    AURORA III
    
    Citigroup Diversified Futures Fund L.P.
    
    Citigroup Fairfield Futures Fund L.P. II
    
    CMF Graham Master Fund L.P.
 
   CITIGROUP MANAGED FUTURES LLCBy:
    /s/ Jennifer MagroJennifer MagroChief Financial Officer & Director By:
    /s/ Paul Sedlack Paul Sedlack




---



##### 



Exhibit 10.20
  
  Re: Management Agreement Renewals
   
    
    CMF SandRidge Master Fund LP
    
    CMF SandRidge Feeder (Cayman) Ltd.
    
    Citigroup Energy Advisors Portfolio L.P.
    
    SSB Diversified 2000 Futures Fund L.P.
  Very truly yours,

CITIGROUP MANAGED FUTURES LLCBy:
    /s/ Jennifer MagroJennifer MagroChief Financial Officer and DirectorBy:
    /s/ Andrew M. Rowe Andrew M. Rowe




---



##### 



Exhibit 10.20
  
  Re: Management Agreement Renewal
   
    
    Citibank NA (Alera 100)
    
    CMF Eckhardt Master Fund L.P.
    
    SSB Diversified 2000 Futures Fund L.P.
    
    SB Diversified Futures Fund L.P.
    
    SB Diversified Futures Fund L.P. II
    By:
    
    /s/ Jennifer MagroJennifer MagroChief Financial Officer and DirectorECKHARDT
TRADING COMPANYBy:
    
    /s/ John D. Fornengo
 John D. Fornengo
1

UNITED STATES DISTRICT COURT

SOUTHERN DISTRICT OF NEW YORK

-----------------------------------------------------X

In the Matter of the Application of C.B. on

Behalf of Z.G., her minor child NOTICE OF MOTION

07 Civ. 3419 (AKH)

Plaintiffs,

 -againstDEPARTMENT OF EDUCATION OF THE

CITY OF NEW YORK,

Defendant. 

-----------------------------------------------------X

PLEASE TAKE NOTICE, that upon the accompanying Plaintiffs’ Statement of

Material Facts Not In Dispute, dated September 20, 2007, the Plaintiff, C.B. on Behalf of

Z.G. , will move this Court, before the Honorable Alvin K. Hellerstein, at the United States

Courthouse for the Southern District of New York, located at 500 Pearl Street, New York,

New York 10007, on the 14th day of November, 2007, at 9:30 A.M., or as soon thereafter

as counsel may be heard, for an order pursuant to Fed. R. Civ. P. 56 awarding plaintiff

summary judgment in its favor, together with such other and further relief as the Court

may deem just and proper.

PLEASE TAKE FURTHER NOTICE that opposition papers, if any, are to be

served by October 26, 2007.

Dated: New York, New York

 September 20, 2007

Respectfully submitted,

s/Neal H. Rosenberg, Esq. 

NEAL H. ROSENBERG (NHR 7827)

Attorney for Plaintiffs

9 Murray Street, Suite 4 West

New York, New York 10007

(212) 732-9450

Case 1:07-cv-03419-AKH Document 8 Filed 10/05/2007 Page 1 of 3
2

To: MICHAEL A. CARDOZO

Corporation Counsel of the

 City of New York

Attorney for Defendant

100 Church Street, Room 2-317

New York, New York 10007

(212) 788-0878

By: ___________________________

 ANDREW RAUCHBERG

 Assistant Corporation Counsel

Case 1:07-cv-03419-AKH Document 8 Filed 10/05/2007 Page 2 of 3
3

CERTIFICATE OF SERVICE

I hereby certify that the foregoing Notice of Motion was served via EC Filing

system to Michael A. Cardozo, Corporation Counsel of the City of New York, Attorney

for the Plaintiff, 100 Church Street, Room 2-121, New York, New York 10007, by Andrew

J. Rauchberg (AR 2179), Assistant Corporation Counsel.

s/Stewart L. Karlin 

Case 1:07-cv-03419-AKH Document 8 Filed 10/05/2007 Page 3 of 3
```

[Federal Register Volume 70, Number 227 (Monday, November 28, 2005)]
[Notices]
[Page 71324]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-23347]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Institute of General Medical Sciences; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of General Medical 
Sciences Special Emphasis Panel, MBRS Support of Continuous Research 
Excellence.
    Date: December 7, 2005.
    Time: 1 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Room 3AN-12, Bethesda, MD 20892 (Telephone Conference 
Call).
    Contact Person: Meredith D. Temple-O'Connor, PhD, Office of 
Scientific Review, National Institute of General Medicinal Sciences, 
National Institutes of Health, 45 Center Drive, Room 3AN18, 
Bethesda, MD 20892, 301-594-2772, [email protected].
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.375, 
Minority Biomedical Research Support; 93.821, Cell Biology and 
Biophysics Research; 93.859, Pharmacology, Physiology, and 
Biological Chemistry Research; 93.862, Genetics and Development 
Biology Research; 93.88, Minority Access to Research Careers; 93.96, 
Special Minority Initiatives, National Institutes of Health, HHS)

    Dated: November 16, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-23347 Filed 11-25-05; 8:45 am]
BILLING CODE 4140-01-M
```
Case 1:07-cv-03474-NRB Document 1 Filed 05/01/2007 Page 1 of 10
Case 1:07-cv-03474-NRB Document 1 Filed 05/01/2007 Page 2 of 10
Case 1:07-cv-03474-NRB Document 1 Filed 05/01/2007 Page 3 of 10
Case 1:07-cv-03474-NRB Document 1 Filed 05/01/2007 Page 4 of 10
Case 1:07-cv-03474-NRB Document 1 Filed 05/01/2007 Page 5 of 10
Case 1:07-cv-03474-NRB Document 1 Filed 05/01/2007 Page 6 of 10
Case 1:07-cv-03474-NRB Document 1 Filed 05/01/2007 Page 7 of 10
Case 1:07-cv-03474-NRB Document 1 Filed 05/01/2007 Page 8 of 10
Case 1:07-cv-03474-NRB Document 1 Filed 05/01/2007 Page 9 of 10
Case 1:07-cv-03474-NRB Document 1 Filed 05/01/2007 Page 10 of 10
Case 1:07-cv-03413-LAP Document 34 Filed 03/31/2008 Page 1 of 1
#### STATE v. BRYANT and STATE v. FLOYD

No. 107 PC.

Case below: 16 N.C. App. 456.

Petition for writ of certiorari to North Carolina Court of Appeals denied 18 January 1973. Appeal dismissed for lack of substantial constitutional question 18 January 1973.
#### BANK v. HARWELL

No. 127 PC.

Case below: 38 N.C. App. 190.

Petition by defendant for discretionary review under G.S. 7A-31 denied 4 January 1979.
Case 1:07-cv-03497-LAK Document 3 Filed 05/03/2007 Page 1 of 4
Case 1:07-cv-03497-LAK Document 3 Filed 05/03/2007 Page 2 of 4
Case 1:07-cv-03497-LAK Document 3 Filed 05/03/2007 Page 3 of 4
Case 1:07-cv-03497-LAK Document 3 Filed 05/03/2007 Page 4 of 4
Case 1:07-cr-00376-VM Document 12 Filed 01/25/2008 Page 1 of 1
EXHIBIT 31.1

RULE 13a-14(a)/15d-14(a) CERTIFICATION

OF CHIEF EXECUTIVE OFFICER

I, Michael
Willoughby, certify that:

1. I have reviewed this annual report on Form 10-K/A of PFSweb, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were made, not misleading with respect to the periods covered by this report;



|      |  |                        
|----- |  | -----------------------
|Date: |  | April 30, 2015         
|      | 
|By:   |  | /s/ MICHAEL WILLOUGHBY 
|      |  | Chief Executive Officer
Case 7:07-cv-03432-CS-MDF Document 11-15 Filed 07/17/2007 Page 1 of 24Case 7:07-cv-03432-CS-MDF Document 11-15 Filed 07/17/2007 Page 2 of 24Case 7:07-cv-03432-CS-MDF Document 11-15 Filed 07/17/2007 Page 3 of 24Case 7:07-cv-03432-CS-MDF Document 11-15 Filed 07/17/2007 Page 4 of 24Case 7:07-cv-03432-CS-MDF Document 11-15 Filed 07/17/2007 Page 5 of 24Case 7:07-cv-03432-CS-MDF Document 11-15 Filed 07/17/2007 Page 6 of 24Case 7:07-cv-03432-CS-MDF Document 11-15 Filed 07/17/2007 Page 7 of 24Case 7:07-cv-03432-CS-MDF Document 11-15 Filed 07/17/2007 Page 8 of 24Case 7:07-cv-03432-CS-MDF Document 11-15 Filed 07/17/2007 Page 9 of 24Case 7:07-cv-03432-CS-MDF Document 11-15 Filed 07/17/2007 Page 10 of 24Case 7:07-cv-03432-CS-MDF Document 11-15 Filed 07/17/2007 Page 11 of 24Case 7:07-cv-03432-CS-MDF Document 11-15 Filed 07/17/2007 Page 12 of 24Case 7:07-cv-03432-CS-MDF Document 11-15 Filed 07/17/2007 Page 13 of 24Case 7:07-cv-03432-CS-MDF Document 11-15 Filed 07/17/2007 Page 14 of 24Case 7:07-cv-03432-CS-MDF Document 11-15 Filed 07/17/2007 Page 15 of 24Case 7:07-cv-03432-CS-MDF Document 11-15 Filed 07/17/2007 Page 16 of 24Case 7:07-cv-03432-CS-MDF Document 11-15 Filed 07/17/2007 Page 17 of 24Case 7:07-cv-03432-CS-MDF Document 11-15 Filed 07/17/2007 Page 18 of 24Case 7:07-cv-03432-CS-MDF Document 11-15 Filed 07/17/2007 Page 19 of 24Case 7:07-cv-03432-CS-MDF Document 11-15 Filed 07/17/2007 Page 20 of 24Case 7:07-cv-03432-CS-MDF Document 11-15 Filed 07/17/2007 Page 21 of 24Case 7:07-cv-03432-CS-MDF Document 11-15 Filed 07/17/2007 Page 22 of 24Case 7:07-cv-03432-CS-MDF Document 11-15 Filed 07/17/2007 Page 23 of 24Case 7:07-cv-03432-CS-MDF Document 11-15 Filed 07/17/2007 Page 24 of 24